In focus

NI+ feature

Maternal and infant supplement launches go for the gut and fourth trimester

12-Mar-2026 | Asia Sherman

Rather than focusing solely on providing basic and broad prenatal vitamin and mineral coverage, brands across global markets are increasingly marketing expanded formulas and stage‑specific maternal and infant nutrition.

News from NI+

Latest insights

Consolidation, partnerships and growth: Supplement industry deals of Q1 2026

31-Mar-2026 | Asia Sherman

The dietary supplement sector continued to roll out deals in early 2026, reflecting a shift toward platform‑driven strategies to cultivate more diversified businesses positioned for long‑term growth in a crowded and evolving market.

What is a ‘dietary substance’? FDA invites comment to move supplement innovation forward

31-Mar-2026 | Stephen Daniells

Advances in biotech and ingredient manufacturing are spurring the FDA to reconsider the boundaries of DSHEA, agency officials said at a public meeting on dietary ingredients. From plant cell culture and precision fermentation to ingredients like probiotics and peptides, advancing science and emerging technologies are challenging long‑standing interpretations of what qualifies as a ‘dietary substance’.

Digital ‘gut twins’ are a step closer to predicting probiotic success

30-Mar-2026 | Lauren Nicolle

Gut microbes are often categorized into two groups: ‘good’ or ‘bad’. However, new research adds weight to the idea that this classification is oversimplified, showing that different bacteria are likely to confer different health effects depending on individual gut microbiome compositions.

The perils of the GLP-1 rebound and the off-ramp opportunity

26-Mar-2026 | Asia Sherman

For many patients, discontinuing GLP-1 treatment after short-term use is followed by rapid weight regain and the erosion of hard-won metabolic gains.

Weight Management Summit 2026 in pictures

26-Mar-2026 | Cassandra Stern

This year’s Weight Management Summit brought together academia and supplement industry stakeholders for discussions surrounding how GLP-1 receptor agonist drugs continue to reshape the category.

People on the move: New nutra jobs of winter 2025-2026

23-Mar-2026 | Asia Sherman

Recent leadership movements across the nutrition, dietary supplement and natural products sectors reflect an industry placing renewed emphasis on experience, scientific credibility and operational depth amid ongoing market and regulatory complexity.

From periphery to curriculum: Considering higher education in dietary supplements

20-Mar-2026 | Claudia Adrien

In the fall of 2024, the University of Mississippi admitted the first cohort to its online Master of Science in Dietary Supplements and Medical Cannabis, created to educate professionals in the science, regulation and manufacturing of natural products and cannabis.

Beyond breastmilk: Ummino brings HMO science to the adult gut

19-Mar-2026 | Lauren Nicolle

North Carolina State University spinout Ummino is preparing to commercialize its clinically validated prebiotic, marketed as Hummino, after nearly two decades of microbiome research.

Establishing creatine reference intakes for adults

18-Mar-2026 | Asia Sherman

A new evidence‑based framework proposes dietary reference intakes for creatine in healthy adults, positioning the compound as a conditionally essential nutrient and raising fresh questions about adequacy in populations with low animal‑protein intake.

intelligent Answers

Ask iA

Ask iA

Get clarity with intelligent Answers

Subscribers get unlimited use of iA for deep research of over 25 years of NutraIngredients reporting.

Ask a question.